DrugBank is the world’s largest online database of drug and drug target information. DrugBank augments human intelligence to improve the world’s health. We offer a suite of products that enable companies to improve healthcare delivery through precision medicine or clinical software application and uncover insights through data science in drug discovery. Our publicly accessible resource, DrugBank Online, has been cited in over 13,000 academic publications and is used by millions of researchers and health professionals globally.

DrugBank started in 2006 in Dr. David Wishart’s lab at the University of Alberta. DrugBank started as a project to make it easier for academic researchers to get detailed structured information about drugs. Since 2006, DrugBank has rapidly grown in scope and popularity. With growing commercial interest, in 2016, the project was commercialized and the DrugBank IP was licensed to OMx Personal Health Analytics Inc. a company founded by Dr. David Wishart, Craig Knox, and Michael Wilson.

Since 2016, DrugBank has continued to grow in popularity and has developed numerous additional datasets, software tools, and APIs. Supporting academic research and student education remains a core part of our mission and in addition to commercial offerings, DrugBank continues to provide free, non-commercial datasets to academic researchers and a free version of DrugBank data, accessible at go.drugbank.com.

Today DrugBank has been cited in over 7,000 academic publications and has enabled groundbreaking research in drug discovery, machine learning, and drug repurposing. Thousands of graduate students have used DrugBank data as a core part of their research and education and DrugBank is accessed by millions of people each year from over 150 countries. DrugBank provides information to many important organizations around the world including the Food and Drug Administration, Health Canada, the National Institute of&